Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
Official title: The Impact of Prenatal Exercise Type and Intensity on Glucose Control in Pregnant Women
Run by University of Central Arkansas · NCT07802262 · Data updated 2026-11-12
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | Women only |
| Enrollment | 23 (estimated) |
| Sponsor | University of Central Arkansas Academic / other |
| Locations | 1 site (Conway, Arkansas) |
| Status | Recruiting |
| Started | September 24, 2024 |
| Main results expected | August 31, 2027 |
| Study ends | January 31, 2028 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT07802262 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are sedentary women, 18–35 years old, with a singleton pregnancy at 24–30 weeks gestation and a diagnosis of gestational diabetes, who are otherwise healthy and not using glucose-affecting medications.
✕Probably not a fit
Pregnant individuals with contraindications to exercise or those not meeting eligibility criteria may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial compares acute exercise sessions of different types (aerobic vs. resistance training) and intensities to see how they affect glucose regulation and insulin sensitivity in pregnant women with gestational diabetes. Eligible participants are sedentary, 24–30 weeks pregnant, and meet other criteria; sessions are conducted in the university lab setting. The study aims to identify which exercise approach best supports glucose control in GDM. Results could help tailor prenatal exercise prescriptions to improve maternal and fetal health.
Why it matters
Potential benefit: If successful, the approach could offer nonpharmacologic options to improve glucose control for pregnant people with GDM.
How similar studies have gone: Prior work supports benefits of exercise on glucose regulation in similar insulin-resistant populations, but direct comparisons of prenatal aerobic versus resistance modalities in GDM are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biological female * Singleton (one fetus) * 24-30-wks gestation * 18-35 yrs old * Sedentary * Conception without the use of assisted fertility treatments Exclusion Criteria: * Existing other metabolic disorders * Currently taking medication or supplements that affect glucose metabolism * Taking drugs, tobacco, or alcohol during pregnancy * Having a contraindication to exercise
Where it's running
-
Human Performance Laboratory (HPL) at the University of Central Arkansas
Conway, Arkansas, United States Recruiting
Study contacts
- Principal investigator: Brittany R Tucker, PhD — University of Central Arkansas
- Study coordinator: Brittany R Tucker, PhD
- Email: rallman@uca.edu
- Phone: 484-802-6852
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Islet function in gestational diabetes: see if pancreas changes during and after pregnancy
This study tests whether the human pancreas changes its function during and after pregnancy in people with gestational diabetes or not, using Exendin 9-39 in a small Phase 1 trial.
-
Alpelisib Challenge Test to measure insulin secretory capacity
Researchers will test a new approach to measure how much insulin the body can produce in people at various weights and with or without insulin resistance, using alpelisib around a meal test.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.